Remedium Bio
Needham, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Remedium Bio
Founders & leadership
LF
Luppino FrancescoNamed on SEC filing
Investors · 1
Funding
SEC filings, press & company announcements$5.9M disclosed across 2 of 3 rounds · 2021–2026
- Undisclosed amountExpanded Seed FundingAug 2022Source ↗
▶$1.5MraisedMay 2026 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexei GoraltchoukExecutive Officer, Director
- Frank LuppinoExecutive Officer, Director
- Harry RobbDirector
- Richard HagueDirector
- Offering amount
- $10M
- Amount sold
- $1.5M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedAug 2024 · 26 investors · BiotechnologyRule 506(b)
▶$4.4MraisedAug 2024 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luppino FrancescoExecutive Officer, Director
- Offering amount
- $7.3M
- Amount sold
- $4.4M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
VC funding deals: Aureka Biotechnologies, NdotLight, Remedium Bio - InfotechLeadinfotechlead.com · Aug 2026
Lifespan Vision Ventures Leads Remedium Bio's Series A Financing - BioSpacebiospace.com · Aug 2026Frequently asked questions
- Who are Remedium Bio's investors?
- Remedium Bio's investors include HKX Capital.
- How much funding has Remedium Bio raised?
- Remedium Bio has disclosed $5.9M raised across 2 of its 3 known rounds.
- Where is Remedium Bio headquartered?
- Remedium Bio is headquartered in Needham, US.